What is Pulse Biosciences, Inc.'s revenue?

Pulse Biosciences, Inc. (PLSE) generated $751.0K in revenue over the trailing twelve months.

Is Pulse Biosciences, Inc. profitable?

Pulse Biosciences, Inc. is not currently profitable: it reported a net loss of $74.6M over the trailing twelve months, a -9929.0% net margin.

What are Pulse Biosciences, Inc.'s profit margins?

Gross margin is -4067.5% and operating margin is -10392.1%, with a -9929.0% net margin.

Where does Pulse Biosciences, Inc.'s income statement data come from?

Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Pulse Biosciences, Inc. PLSE Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Gross profit	——	——	——	——	——
Selling, general and administrative	$30.89M-3.6%	$32.03M-6.6%	$34.3M+9.0%	$31.47M—	——
Net income	-$74.57M-2.5%	-$72.78M+2.6%	-$74.73M-9.9%	-$68.03M-12.9%	-$60.24M-12.4%
Amortization of capitalized software and acquired intangible assets	$666K+0.2%	$665K0.0%	$665K-0.2%	$666K+0.2%	$665K-0.2%
Depreciation	$381K-7.1%	$410K-6.4%	$438K0.0%	$438K0.0%	$438K-3.3%
Accounts payable	——	——	$1.31M—	——	——
Increase (Decrease) in Accounts Receivable	——	——	——	——	——
Accrued liabilities	——	——	——	——	$1.72M-46.6%
Increase (Decrease) in Inventories	$176K+29.4%	$136K+139%	$57K+11.8%	$51K+70.0%	$30K—
Increase (Decrease) in Prepaid Expense and Other Assets	$760K-16.7%	$912K—	——	——	——
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	$4.56M-73.4%	$17.15M-73.6%	$64.98M-48.0%	$124.91M0.0%	$124.91M+13.1%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$323K+3.6%	-$335K-18.4%	-$283K-9.3%	-$259K-57.0%	-$165K-32.0%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	-$55.2M-2.0%	-$54.12M-11.6%	-$48.51M-9.0%	-$44.5M-11.0%	-$40.08M-10.3%
Other income, net (Note 6)	-$70K-34.6%	-$52K+8.8%	-$57K-46.2%	-$39K—	——
Other Receivable From Exercise Of Warrants And Stock Options	——	——	——	——	$69K-25.0%
Payments Of Stock Issuance Costs	$57K—	$0-100%	$59K—	——	——
Payments to Acquire Property, Plant, and Equipment	$303K-3.8%	$315K+19.8%	$263K+10.0%	$239K+44.8%	$165K+32.0%
Cash received from option exercises	$3.78M+52.0%	$2.49M+0.6%	$2.47M+99.3%	$1.24M-0.1%	$1.24M+42.6%
Proceeds from issuance of common stock relating to employee stock plans	——	——	——	——	——
Stock-based compensation	$17.69M-17.6%	$21.46M-7.8%	$23.28M+12.8%	$20.65M+17.9%	$17.51M+28.9%
EBITDA	-$77M-1.5%	-$75.86M+2.5%	-$77.84M-9.4%	-$71.13M-13.7%	-$62.58M-13.5%
EBIT	-$78.05M-1.4%	-$76.94M+2.5%	-$78.95M-9.3%	-$72.24M-13.4%	-$63.69M-13.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Pulse Biosciences, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s revenue?: Pulse Biosciences, Inc. (PLSE) generated $751.0K in revenue over the trailing twelve months.
Is Pulse Biosciences, Inc. profitable?: Pulse Biosciences, Inc. is not currently profitable: it reported a net loss of $74.6M over the trailing twelve months, a -9929.0% net margin.
What are Pulse Biosciences, Inc.'s profit margins?: Gross margin is -4067.5% and operating margin is -10392.1%, with a -9929.0% net margin.
Where does Pulse Biosciences, Inc.'s income statement data come from?: Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.